遗传学,病理生理学和希佩尔-林道氏病治疗方法的当前挑战
Laura Gómez-Virgilio1, Mireya Velazquez-Paniagua1, Lucero Cuazozon-Ferrer1,2
1Laboratory of Cellular Reprogramming, Department of Physiology, Facultad de Medicina, Universidad Nacional Autónoma de México, Av. Universidad No. 3000, Coyoacan CDMX 04510, Mexico.
希佩尔-林道氏病 (VHL) 是一种遗传性疾病,由于VHL基因突变导致瘤. 管理具有挑战性,需要持续研究以获得更好的疗法和监测.
科学领域:
- 遗传学和分子生物学
- 在瘤学瘤学.
- 罕见疾病 罕见疾病
背景情况:
- ·希佩尔-林道 (VHL) 病源于染色体3上的VHL瘤抑制基因的突变.
- 这些突变,无论是遗传的还是自发的,导致VHL蛋白 (pVHL) 的功能丧失.
- 通常情况下,pVHL调节缺氧诱导因子 (HIF),这对细胞生长和存活至关重要.
研究的目的:
- 提供关于·希佩尔-林多 (VHL) 疾病的全面审查.
- 详细介绍VHL疾病的遗传基础,病理生理学,临床表现,诊断和治疗.
- 突出VHL疾病管理当前的挑战和未来的研究方向.
主要方法:
- 审查关于VHL疾病的现有文献.
- 分析基因突变及其对pVHL功能的影响.
- 收集关于临床表现,诊断方法和治疗策略的信息.
主要成果:
- VHL疾病会影响多个器官,包括大脑,脊髓,视网膜,脏,胰腺和上腺.
- 瘤的发展和囊的形成是特征性的表现.
- 症状因瘤的位置和大小而异.
结论:
- 诊断依赖于临床标准,成像和遗传检测.
- 治疗主要涉及手术,辐射疗法作为一种选择.
- 对某些瘤类型缺乏有效的治疗方法,强调需要改善监测和研究新型治疗方法的必要性.
更多相关视频
08:26A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay
Published on: April 12, 2018
07:04Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
相关概念视频
Regulation of Angiogenesis and Blood Supply
Lysosomal Hydrolases
iPS Cell Differentiation
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Mechanism of Angiogenesis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
